ERCC1 Cys8092Ala and XRCC1 Arg399Gln polymorphisms predict progression-free survival after curative radiotherapy for nasopharyngeal carcinoma.

by Hekun Jin, Xiaoxue Xie, Hui Wang, Jun Hu, Feng Liu, Zhigang Liu, Jumei Zhou, Yingying Zhang, Xuping Xi, Bingqiang Hu, Yuping Liao, Jingtian Tang
Published 2014-01-01